Reinvestigation of the Two-step Synthesis of Sevoflurane

Authors

Abolghasem Moghimia, Mostafa Vojdania, b,*, Ali R. Banana, Ahmad Mollaeia, Mojtaba Mahmoodiana, Sayyed Mojtaba Moosavia
aDepartment of Chemistry, Imam Hossein University, Tehran, Iran.
bDepartment of Nuclear Medicine, The Educational, Research and Clinical Center, Dr. Masih Daneshvari Hospital, Tehran, Iran.
*Corresponding Author: Corresponding author: E-mail: [email protected] Email:

IJ Pharmaceutical Research:Vol. 14, issue 3; 733-738
Published online:Jul 31, 2015
Article type:Original Article
Received:Dec 31, 2013
Accepted:Oct 31, 2014
How to Cite:Moghimi A, Vojdani M, R. Banan A, Mollaei A, Mahmoodian M, et al. Reinvestigation of the Two-step Synthesis of Sevoflurane. Iran J Pharm Res. 2015;14(3):e125309. doi: https://doi.org/10.22037/ijpr.2015.1684

Abstract

Improvements in the two-step synthesis of 1,1,1,3,3,3-hexafluoro-2- (fluoromehoxy)propane (Sevoflurane) that result in the product cost reduction, safety level enhancement and positive environmental impacts are described. This process consists of chloromethylation reaction of 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) followed by a halogen-exchange fluorination. This is the first synthesis of Sevoflurane in Iran which was successfully scaled up. During this work, several improvements have been achieved by optimization of the reaction time, the amount of consumed starting materials and solvents and work up procedure while keeping the yield and purity intact. The reaction time of the first step (24 h) was diminished to 4 h. 19F NMR spectroscopy was used to investigate the rate of the reaction in the first step and to evaluate the influence of different parameters mentioned on the achieved improvements.

Highlights

Introduction

Sevoflurane,1,1,1,3,3,3-hexafluoro-2-( fluoromehoxy )-propane, is an important and widely used nonflammable general inhalation anesthetic in the world. Although a number of methods have been introduced by different research groups (1-4), three methods have gained more interest for the industrial production of Sevoflurane (Scheme 1). The single-step synthetic process involves the reaction of 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) and stoichiometric excess of paraformaldehyde and HF in the presence of fuming sulfuric acid. In this one pot method, a large quantity of chemically aggressive species may cause corrosion of the plant during the process and would also circumvent the problems associated with the handling of highly toxic HF. The three-step method involves, i) reaction of HFIP with a methylating agent such as dimethylsulfate to form sevomethyl ether (1), ii) photochemical chlorination of sevomethyl ether 1 to form Sevochlorane (2), and iii) substitution of the chlorine of Sevochlorane through a Halogen-exchange reaction. In this process, dimethylsulfate and chlorine gas must be handled which are both toxic. In addition, the low yield of the second step was the other disadvantages of this process.
The single, two and three-step synthetic methods of Sevoflurane from hexafluoroisopropanol
Scheme 1
The single, two and three-step synthetic methods of Sevoflurane from hexafluoroisopropanol
The third process has been introduced by C. Bieniarz et al. as a two-step, efficient, safe and amenable method. The overall yield has been differently reported from 65 to 70% with purity in the range of 99.40-99.95% depending on the procedure (2, 3).
Our investigations on this process, clarified some disadvantages that could be partially or totally removed. The disadvantages are: i) long reaction time, 24 h, for the chloromethylation step and ii) large amount of KF and PEG-400 used in the second step, the fluoride exchange reaction. Herein, some modifications that have been applied on this method are discussed in order to reach a more cost-effective process and to decrease the environmental pollutions, compared with other references (2, 3), with no change in yield and purity of the product (Table 1).
Table 1
A comparison with other references
Ref 3Ref 2Ref 6
Present work
Two step processSingle potprocess
Chloromethylation StepMixingAlCl3 (mol)0.139 c64.540.139 c32.370.26
HFIP (mol)0.139 c64.540.139 c32.370.24
1,3,5-Trioxane (mol)0.047 c21.580.046 c10.790.08
Reaction Time (h)242420 fDid not mention4
HCl gas aEvaluatedAbsorbed dEvaluatedAbsorbed dReused i
Monitoring the reaction By GCBy GCBy GCBy GCBy 19F NMR
QuenchingHCl 6N (L)0.05026.60.050 g13.30.040
Water (L)Did not mention clearly100.050 50.040
Aqueous Phase bDid not mentionSiphoned offDid not mentionSiphoned offAnalyzed by 19F NMR j
Quenching TimeDid not mention Did not mentionDid not mention clearlyDid not mention50 minuets k
Fluorination StepSVC (mol)0.010Did not mention e0.010Did not mention e0.18
KF (mol)0.040Did not mention0.04097.26 0.22
PEG-400 (L)0.01032------ h160.050
Produced during the reaction.
Produced by washing the mixture.
The number is rounded. dBy scrubbers containing water.
The SVC didn’t separate because this reaction has been described as a one-vessel process.
The reaction didn’t completed at this time because the mixture still had a little (<5% quantitatively) amount of bis-HFIP-acetal.
Cold (-20 °C.).
diethylene glycol was used as a solvent (0.010 L).
The HCl gas was directed to a water bath and, after pH adjustment, was used for quenching the chloromethylation step.
The aqueous phase contains some SVC that was extracted by a solvent.
The quenching time depends on the reaction scale.

Experimental

Chemicals and apparatus
Hexafluoro-2-propanol, AlCl3, 1,3,5-trioxane, KF, and PEG-400 were purchased from Merck and used as received. Sevoflurane was obtained from Abbott. GC analysis was performed using a Varian 3400 gas chromatograph with a flame ionization detector (FID) through a 2m x l/8" OV-101 on 80/100 CWHP packed GC column. 1H, 19F and 13C NMR were recorded on Bruker NMR spectrometers at 250, 235 and 62.5 MHz, respectively. Chemical shifts are reported in ppm downfield from tetramethylsilane (TMS, δ0.00).
Synthesis of Sevochlorane
Anhydrous AlCl3 (34.9 g, 0.26 mol) was placed into a jacketed glass reactor. The reaction vessel was cooled to 0 ºC, and HFIP (40 g, 0.24 mol) was added in a single portion while stirring. 1,3,5-trioxane (7.2 g, 0.08 mol) was added in portions to the homogeneous slurry of HFIP and AlCl3.The generated HCl gas was directed into a water vessel. After 2 h, the temperature of the reaction mixture was increased to 25 ºC. After 4 h, the reaction mixture was cooled to 0 ºC and the careful dropwise addition of cooled water (40 g) started. When adding water was completed, and the exothermic reaction was subsided, 6 N HCl (40 mL) was added rapidly in one portion. Then, the bath temperature was increased to ambient temperature and stirrer rate was increased to dissolve all the remaining aluminate salts. Consequently, three clear layers appeared. The bottom layer (Sevochlorane phase) was separated and washed twice with water and then dried over MgSO4 to afford 45 g (87.2%) highly pure Sevochlorane. Data for 1,1,1,3,3,3-hexafluoro-2-(chloromethoxy)-propane (1): bp = 76 °C; 1H NMR (250.1 MHz, CDCl3): δ 5.57 (s, 2H) 4.54 (septet, 1H, 3JHF = 5.7 Hz); 19F NMR (235.4 MHz, CDCl3): δ -74.14 (d, 3JHF = 5.9 Hz ); 13C NMR (62.9 MHz, CDCl3): δ 121.0 (q, 1JFC = 283.0 Hz) 80.4 (s), 73.8 (septet, 2JFC= 31.4 Hz).
Halogen-exchange fluorination
PEG-400 (50 mL) was placed into a jacketed glass reactor. KF (12.9 g, 0.22 mol) was added thereafter while stirring. Then, Sevochlorane (40 g, 0.18 mol)was added to the mixture and the reaction mixture was heated at 90 ºC for 2 h, and then cooled down to room temperature. Water (50 mL) was added to the mixture. Two clear phases had formed. The bottom phase was separated, dried over MgSO4, and distilled to afford 27 g (72%) of highly pure Sevoflurane (99.9%). Data for 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane (Sevoflurane, 3): bp = 58.5 °C; 1H NMR (250.1 MHz, CDCl3): δ 5.42 (d, 2H, 2JHF = 53.5 Hz) 4.42 (septet, 1H, 3JHF = 5.7 Hz); 19F NMR (235.4 MHz, CDCl3): δ -75.13 (dd, 3JHF = 4.7 Hz, 5JFF= 2.4 Hz ), -155.65 (septet of t, 2JHF = 54.13 Hz, 5JFF= 2.4 Hz); 13C NMR (62.9 MHz, CDCl3): δ 121.1 (q, 1JFC = 283.0 Hz) 103.1 (d, 1JFC = 226.4 Hz), 74.24 (septet, 2JCF= 33.4 Hz).

Results and Discussion

The first modification applied for the two-step process was the first step reaction time that was decreased to 4 h by changing the ratio of the starting materials. The next modification was reducing the amount of solvent and KF, in the second step, with no change on the yield and purity of the product. These modifications would change the original two-step method into a real cost-effective process.
The chloromethylation reaction of HFIP has been reported to take 24 h and a 1:1:0.3 molar ratio for HFIP, AlCl3 and trioxane, respectively, has been used (2, 3). In order to decrease the full conversion time for the first step, the solvent effect was initially investigated. The application of chloroform and dichloromethane resulted in the synthesis of sevochlorane in low yield. Tetrachloroethane led to the formation of bis (HFIP) acetal by-products. Therefore, this solvent has been proposed for the preparation of bis-acetal. Afterwards our attention was shifted to the effect of reagent ratios on the reaction kinetics and reaction yield. It was found out that increasing the amount of AlCl3 (only 10 mol%) would sharply accelerates this reaction within the first 2 h and approximately 100% conversion was achieved after 4 h. Increasing the excess value of AlCl3 by more than 10% or increasing the amount of trioxane, didn't show further acceleration (Figures 1 and 2).
Monitoring the Chloromethylation Reaction by <sup>19</sup>F NMR Using 10% Excess of AlCl<sub>3</sub>.
Figure 1
Monitoring the Chloromethylation Reaction by 19F NMR Using 10% Excess of AlCl3.
Kinetics of HFIP chloromethylation reaction followed by <sup>19</sup>F NMR spectroscopy
Figure 2
Kinetics of HFIP chloromethylation reaction followed by 19F NMR spectroscopy
The next issue was the high volume of water and acid used for quenching. The addition of 6 N HCl solution to interrupt the reaction, increases the reaction temperature violently, and consequently results in partial product loss by decomposition, evaporation, and polymerization which decreases the first step yield. Considering these disadvantages the aqueous acid and water addition sequence was changed and the bath temperature was increased to dissolve the aluminate salts sufficiently. The HCl gas was conducted to a water vessel and this aqueous HCl, after pH adjustment, was used at the end of the first step (quenching) to dissolve the aluminate salt. The applied changes would certainly reduce environmental pollution and costs.
An important question in relation to the separation of the organic phase in the first step is whether there is any Sevochlorane in the aqueous phase. This question was positively answered by 19F NMR analyzing of aqueous phases using 2,2,2-trifluoroethanol, as an internal standard. Thus, all the aqueous phases (used for quenching or washing the organic phase, which were all siphoned off by Bieniarz et al.) were recycled and reused in the next batches.
Halogen-exchange (Halex) fluorination is an important method in preparing fluorinated compounds. Different reagents such as KF, HF, BrF3, Bu4N+F-, F2, and CsF have been used for this purpose (4-8). Among them, KF, which presents the best ratio between cost and reactivity, is the most popular reagent to perform the "Halex" reaction on a large scale (5). In order to increase the efficiency of KF, severalphase-transfer catalysts such as 18-crown-6, poly (ethylene glycol) (PEG-400) and polar aprotic solvents such as DMSO, DMF and sulfolane have been reported (5-10).Among these, the best result has been obtained when using PEG-400 as the solvent in the case of Sevochlorane (2, 3).
The fluorination of Sevochlorane (SVC) by KF has been reported in the literature and 2.5-7 equivalents of fluoride to SVC have been recommended (2, 3). Trying to reduce the consumed KF and PEG-400 was the main question in this part of our study. To achieve this goal, several reactions using different weight ratios of KF/SVC and PEG/SVC were performed. As shown in Table 2, it is possible to affirm that a decrease of 4 times in the PEG amount (entries 3 and 4) lead to a decrease of less than 1% of sevoflurane conversion and the same is observed when the KF amount is decreased (entries 2 and 3). Accordingly, the amount of KF was decreased to 1.2 mol per each mol of Sevochlorane and the solvent volume was decreased to 3.7 times that of Sevochlorane. An experiment was also carried out using catalytic amount of PEG but the result was not satisfactory because reaching the desired yield required a much longer time (Table 2).
Finally, Sevoflurane was simply isolated from the reaction mixture by the addition of water to the reaction mixture and the organic phase was separated and dried. Analysis of the aqueous phase showed the presence of Sevoflurane. Therefore this phase was used instead of distilled water in subsequent batches. After several batches, tetrachloroethane was added to the accumulated aqueous phases and Sevoflurane was extracted and then the organic phase was distilled to get even more Sevoflurane.
Table 2
Influence of amount of solvent and KF on the fluorination of Sevochlorane
EntryaPEG-400/mLKF/mol L-1Time/hSevoflurane yield (%)bUnreacted Sevochlorane (%) b
120 0.07 2.596.43.6
220 0.042.595.54.5
320 0.022.594.55.5
45 0.022.593.66.4
52.5 0.022.590.39.7
60.5 0.022.541.858.2
70.5 0.02551.148.9
All reactions were carried out on a 0.016 mol reaction scale of Sevochlorane in PEG-400 at 95 °C.
19F NMR assay.

Conclusion

The two-step synthesis of Sevoflurane has been reinvestigated. Accordingly, the reaction time of the first step was lowered to 4 h and the amount of KF and PEG-400 used in the second step was optimized to minimize the product cost and environmental pollutions. As the solvents were investigated in the first step, tetrachloroethane was found to be a good solvent to direct the chloromethylation step to the bis-HFIP-acetal product. All the aqueous phases, which were all siphoned off by the previous works, were analyzed for the first time and it was found out that these phases contain some product (Sevochlorane and Sevoflurane) that could be recycled. Therefore all these phases together with HCl gas, produced during the first step, were reused in the next batches to decrease the environmental pollutions. Finally all the reactions were monitored by 19F NMR for the first time. This process could be easily implemented on larger scales.

References

  • 1.
    Baker MT. Sevoflurane: are there differences in products? Anesth. Analg. 2007;104:1447-1451.
  • 2.
    Ramakrishna K, Behme C, Schure RM, Bieniarz C. A safe and efficient process for the synthesis of the inhalation anesthetic sevoflurane. Org. Proc. Res. Dev. 2000;4:581-584.
  • 3.
    Bieniarz C, Behme C, Ramakrishna K. An efficient and environmentally friendly synthesis of the inhalation anesthetic sevoflurane. J. Fluorine Chem. 2000;106:99-103.
  • 4.
    Bin-Dong L, Chun-Xu L. Synthesis of Sevoflurane in Ionic Liquids by Halogen-exchange Fluorination. Chinese J. Applied. Chem. 2009;26:1126-1128.
  • 5.
    Langlois B, Gilbert L, Forat G. A new family of delocalized lipophilic cations. Indust. Chem. Library. 1996;8:244-248.
  • 6.
    Yoneda N. Progress in the preparation of organo-fluorine compounds using HF or HF–base molten salts. J. Fluorine Chem. 2000;105:205-207.
  • 7.
    Marjan Esfahanizadeh, Koroush Omidi, Joel Kauffman, Ali Gudarzi, Shahram Shahraki Zahedani, Salimeh Amidi, Farzad Kobarfard. Synthesis and evaluation of new fluorinated anti-tubercular compounds. Iran. J. Pharm. Res. 2014;13:115-126. [PubMed ID: 24734062].
  • 8.
    Ahmad Mohammadi-Farani, Neda Heidarian, Alireza Aliabadi. N-(5-Mercapto-1,3,4-thiadiazol-2-yl)-2-phenylacetamide derivatives: synthesis and in-vitro cytotoxicity evaluation as potential anticancer agents. Iran. J. Pharm. Res. 2014;13:487-492. [PubMed ID: 25237343].
  • 9.
    LuoJ, LüCX, QüW. A polymer onium acting as phase-transfer catalyst in halogen-exchange fluorination promoted by microwave. J. Fluorine Chem. 2004;125:701-704.
  • 10.
    Zheng Yong Liang, Chun Xu Lü, Jun Luo, Li Bin Dong. A polymer imidazole salt as phase-transfer catalyst in halex fluorination irradiated by microwave. J. Fluorine Chem. 2007;128:608-611.

Copyright

© 2015 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Similar Articles

28
May
2012

SiO2/H2SO4: An Efficient Catalytic System for Solvent-free 1, 5-benzodiazepines Synthesis

Mohammad Reza Shushizadeh,
Narges Dalband

Shushizadeh MR, Dalband N. SiO2/H2SO4: An Efficient Catalytic System for Solvent-free 1, 5-benzodiazepines Synthesis. Jundishapur J Nat Pharm Prod. 2012;7(2):61-64. doi: https://doi.org/10.17795/jjnpp-3624

18
Jun
2022
Maintenance of Anesthesia in Paranasal Endoscopic Sinus Surgery: Sevoflurane or Isoflurane? Which One Is Better?

Maintenance of Anesthesia in Paranasal Endoscopic Sinus Surgery: Sevoflurane or Isoflurane? Which One Is Better?

Behzad Ahsan,
Milad Masaeli,
Mohammad Azad Majedi,
Ebrahim Ghaderi,
Tayyebe Faraji

Ahsan B, Masaeli M, Majedi MA, Ghaderi E, Faraji T. Maintenance of Anesthesia in Paranasal Endoscopic Sinus Surgery: Sevoflurane or Isoflurane? Which One Is Better?. J Clin Res Paramed Sci. 2022;11(1):e122247. doi: https://doi.org/10.5812/jcrps-122247

25
Jun
2019

Recovery with Propofol Anesthesia in Children Undergoing Cleft Palate Repair Compared with Sevoflurane Anesthesia

Amany Faheem Omara,
Ahmed Fetouh Abdelrahman,
Maha Lotfy Elshiekh

Omara AF, Abdelrahman AF, Elshiekh ML. Recovery with Propofol Anesthesia in Children Undergoing Cleft Palate Repair Compared with Sevoflurane Anesthesia. Anesth Pain Med. 2019;9(3):e92076. doi: https://doi.org/10.5812/aapm.92076

11
Feb
2026
Comparison of the Effects of Sevoflurane and Isoflurane During Liver Transplant Surgery on the Short-Term Cardiac, Hepatic, and Renal Outcome: A Randomized Clinical Trial

Comparison of the Effects of Sevoflurane and Isoflurane During Liver Transplant Surgery on the Short-Term Cardiac, Hepatic, and Renal Outcome: A Randomized Clinical Trial

Mohammadreza Moshari,
Sadaf Tahery,
Mastaneh Dahi Taleghani,
Shide Dabir,
Maryam Vosoughian,
Soudeh Tabashi
,et al.

Moshari M, Tahery S, Dahi Taleghani M, Dabir S, Vosoughian M, et al. Comparison of the Effects of Sevoflurane and Isoflurane During Liver Transplant Surgery on the Short-Term Cardiac, Hepatic, and Renal Outcome: A Randomized Clinical Trial. Iran J Pharm Res. 2026;25(1):e166290. doi: https://doi.org/10.5812/ijpr-166290

7
Dec
2020
A Comparison of the Sevoflurane and Total Intravenous Anesthesia on the Quality of Recovery in 2 to 10-Year-Old Children

A Comparison of the Sevoflurane and Total Intravenous Anesthesia on the Quality of Recovery in 2 to 10-Year-Old Children

dariush sheikhzade,
Mehdi Razaghipour,
Mahin Seyedhejazi,
Behzad Aliakbari Sharabiani,
Marzieh Marahem

sheikhzade D, Razaghipour M, Seyedhejazi M, Aliakbari Sharabiani B, Marahem M. A Comparison of the Sevoflurane and Total Intravenous Anesthesia on the Quality of Recovery in 2 to 10-Year-Old Children. Inn J Pediatr. 2021;31(1):e105900. doi: https://doi.org/10.5812/ijp.105900

More by these authors

Abolghasem MoghimiPubMedScholar
Mostafa VojdaniPubMedScholar
Ali R. BananPubMedScholar
Ahmad MollaeiPubMedScholar
Mojtaba MahmoodianPubMedScholar
Sayyed Mojtaba MoosaviPubMedScholar
Share
Cited by
Metrics